Exports In 2023, Chile exported $7.34M in Vaccines, blood, antisera, toxins and cultures, making it the 75th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 270th most exported product in Chile. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Chile are: Colombia ($1.6M), Mexico ($1.11M), Argentina ($1.03M), Saudi Arabia ($668k), and Germany ($599k).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Chile between 2022 and 2023 were Mexico ($591k), Brazil ($216k), and Japan ($162k).
Imports In 2023, Chile imported $621M in Vaccines, blood, antisera, toxins and cultures, becoming the 42nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 19th most imported product in Chile. Chile imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($126M), Ireland ($77.6M), Germany ($77.4M), Switzerland ($74.9M), and Norway ($53.9M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Chile between 2022 and 2023 were Italy ($15.7M), Switzerland ($14.4M), and Ireland ($7.58M).